Skip to content
healthcare.dev

Klisyri

NDC 16110-391, tirbanibulin, ointment, from Almirall, LLC.

Product NDC
16110-391
Status
Listed
Labeler
Almirall, LLC
Dosage form
OINTMENT
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213189
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16110-391 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIRBANIBULIN10 mg/g

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
16110-391-05161100391055 PACKET in 1 CARTON (16110-391-05) / .25 g in 1 PACKET
16110-391-55161100391555 PACKET in 1 CARTON (16110-391-55) / .35 g in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/589c8de8-b773-4d47-b60c-48471806cccc

Use it

Look up 16110-391 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16110-391 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16110-391. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.